Topics covered include: the global market in a historical context; and the outlook of "macro misery", having regard to unemployment, inflation, and the likelihood of recession and tighter monetary policy.
Copyright 2022 – Finance News Network
Source: Finance News Network
22 May 2020 - Novonix Limited (ASX:NVX) Managing Director Philip St Baker talks about the company's breakthrough dry particle microgranulation (DPMG) method for reducing waste in the manufacture of anode and cathode materials for lithium-ion batteries, restarting of operations in North America and outlook for 2H20.
Read More23 Dec 2019 - Cyclopharm Limited (ASX:CYC) Managing Director and CEO, James McBrayer talks about the company's joint venture to expand Positron Emission Tomography (PET) diagnostics business opportunities for NSW and Australia.
Read More30 Mar 2022 - Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt discusses encouraging results in second-line non-small cell lung cancer.
Read More30 Jul 2021 - Novatti Group Limited (ASX:NOV) CEO, Peter Cook, provides an update on activities from the company's June quarter, discussing growth in platforms and infrastructure and the recent capital raise.
Read More14 Jun 2024 - Elementos Limited (ASX:ELT) Managing Director Joe David discusses a recent agreement to acquire up to a 50% interest in an operating Spanish tin smelter.
Read More13 Feb 2023 - Splitit Limited (ASX:SPT) CEO Nandan Sheth discusses the buy now, pay later sector, and Splitit's business model partnerships.
Read More06 Sep 2019 - Argo Investments Limited (ASX:ARG) Managing Director, Jason Beddow talks about the Listed Investment Company’s performance, record low interest rates and finding long-term value.
Read More16 Jun 2022 - Knosys Limited (ASX:KNO) Managing Director John Thompson provides an update on the company, discussing demand drivers, recurring revenue and growth strategy.
Read More10 Jul 2024 - Santana Minerals Limited (ASX:SMI) CEO Damian Spring provides an update on the company's progress, discussing an increase in indicated resource at the RAS deposit, expected completion of the prefeasibility study, stakeholder engagement, and the possible impact of the Fast-Track Approvals Bill.
Read More01 May 2020 - Acorn Capital, Head of Portfolio Implementation and Portfolio manager (Healthcare and Biotechnology sectors) Paul Palumbo looks the microcap sector and the recent market sell off and discusses the outlook for next 6 months and longer term.
Read More
